Fig. 1From: SU16f inhibits fibrotic scar formation and facilitates axon regeneration and locomotor function recovery after spinal cord injury by blocking the PDGFRβ pathwaySpatiotemporal distribution of PDGFB and PDGFRβ after SCI. Immunofluorescence staining of PDGFB (red), PDGFRβ (green) and nuclei (blue) in sagittal sections before SCI and at 3, 7, 14 and 28 dpi. The region of interest (ROI) represents the boxed region on the left. Asterisks indicate the injured core. Scale bars: 200 μm in S and 20 μm in TBack to article page